138 related articles for article (PubMed ID: 1913513)
1. Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562/ADM.
Solary E; Velay I; Chauffert B; Bidan JM; Caillot D; Dumas M; Guy H
Cancer; 1991 Oct; 68(8):1714-9. PubMed ID: 1913513
[TBL] [Abstract][Full Text] [Related]
2. Quinine circumvents the doxorubicin resistance of a multidrug resistant human leukemic cell-line, K562/DXR.
Solary E; Velay I; Chauffert B; Caillot D; Bidan JM; Dumas M; Casasnovas O; Guy H
Nouv Rev Fr Hematol (1978); 1990; 32(5):361-3. PubMed ID: 2099412
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of quinine and cinchonine in reversing multidrug resistance on human leukemic cell line K562/ADM.
Genne P; Duchamp O; Solary E; Pinard D; Belon JP; Dimanche-Boitrel MT; Chauffert B
Leukemia; 1994 Jan; 8(1):160-4. PubMed ID: 8289482
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line.
Bennis S; Ichas F; Robert J
Int J Cancer; 1995 Jul; 62(3):283-90. PubMed ID: 7628869
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on reversal efficacy of SDZ PSC 833, cyclosporin A and verapamil on multidrug resistance in vitro and in vivo.
Watanabe T; Tsuge H; Oh-Hara T; Naito M; Tsuruo T
Acta Oncol; 1995; 34(2):235-41. PubMed ID: 7718262
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia.
Solary E; Caillot D; Chauffert B; Casasnovas RO; Dumas M; Maynadie M; Guy H
J Clin Oncol; 1992 Nov; 10(11):1730-6. PubMed ID: 1357108
[TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
Sato W; Fukazawa N; Nakanishi O; Baba M; Suzuki T; Yano O; Naito M; Tsuruo T
Cancer Chemother Pharmacol; 1995; 35(4):271-7. PubMed ID: 7828268
[TBL] [Abstract][Full Text] [Related]
8. Pirarubicin nuclear uptake does not correlate with its induced cell death effect during reversal of multidrug resistance by quinine in human K562 and CEM leukemic cells.
Morjani H; Belhoussine R; Lahlil R; Manfait M
Eur J Haematol; 1998 Oct; 61(4):240-9. PubMed ID: 9820630
[TBL] [Abstract][Full Text] [Related]
9. Modulation of mitomycin C-induced multidrug resistance in vitro.
Dorr RT; Liddil JD
Cancer Chemother Pharmacol; 1991; 27(4):290-4. PubMed ID: 1671830
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells.
Ishida Y; Shimada Y; Shimoyama M
Jpn J Cancer Res; 1990 Aug; 81(8):834-41. PubMed ID: 2118896
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
[TBL] [Abstract][Full Text] [Related]
12. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry].
Belhoussine R; Morjani H; Manfait M
Bull Cancer; 1997 Apr; 84(4):343-9. PubMed ID: 9238156
[TBL] [Abstract][Full Text] [Related]
13. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
Chen JR; Jia XH; Wang H; Yi YJ; Li YJ
Oncol Rep; 2017 May; 37(5):2735-2742. PubMed ID: 28358418
[TBL] [Abstract][Full Text] [Related]
14. Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo.
Genne P; Dimanche-Boitrel MT; Mauvernay RY; Gutierrez G; Duchamp O; Petit JM; Martin F; Chauffert B
Cancer Res; 1992 May; 52(10):2797-801. PubMed ID: 1581892
[TBL] [Abstract][Full Text] [Related]
15. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway.
Zhang X; Ai Z; Chen J; Yi J; Liu Z; Zhao H; Wei H
Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the effects of Siwu Mixture on reversing multidrug resistance of human erythrocyte leukemic cell line K562/ADM].
Xia L; Shen P
Zhongguo Zhong Yao Za Zhi; 2004 Aug; 29(8):792-5. PubMed ID: 15506297
[TBL] [Abstract][Full Text] [Related]
17. Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model.
Lehnert M; Dalton WS; Roe D; Emerson S; Salmon SE
Blood; 1991 Jan; 77(2):348-54. PubMed ID: 1670760
[TBL] [Abstract][Full Text] [Related]
18. FK506 reverses adriamycin resistance in a multidrug-resistant human leukemia cell line.
Natazuka T
Kobe J Med Sci; 1992 Dec; 38(6):347-63. PubMed ID: 1284834
[TBL] [Abstract][Full Text] [Related]
19. Reversal effect of Ganoderma lucidum polysaccharide on multidrug resistance in K562/ADM cell line.
Li WD; Zhang BD; Wei R; Liu JH; Lin ZB
Acta Pharmacol Sin; 2008 May; 29(5):620-7. PubMed ID: 18430371
[TBL] [Abstract][Full Text] [Related]
20. Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement.
Naito M; Tsuruo T
Cancer Res; 1989 Mar; 49(6):1452-5. PubMed ID: 2924298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]